HER2-positive endometrial cancer subtype carries poor prognosis

Sylwia Łapińska-Szumczyk , Anna Supernat , Hanna Majewska , Jacek Gulczyński , Agata Łuczak , Wojciech Biernat , Dariusz Wydra , Anna Żaczek

Abstract

n/a
Author Sylwia Łapińska-Szumczyk
Sylwia Łapińska-Szumczyk,,
-
, Anna Supernat KBM
Anna Supernat,,
- Department of Medical Biotechnology
, Hanna Majewska
Hanna Majewska,,
-
, Jacek Gulczyński
Jacek Gulczyński,,
-
, Agata Łuczak MWB UG i GUMed
Agata Łuczak,,
- Intercollegiate Faculty of Biotechnology UG
, Wojciech Biernat
Wojciech Biernat,,
-
, Dariusz Wydra
Dariusz Wydra,,
-
, Anna Żaczek KBM
Anna Żaczek,,
- Department of Medical Biotechnology
Journal seriesCTS-Clinical and Translational Science, ISSN 1752-8054
Issue year2014
Vol7
No6
Pages482-488
Publication size in sheets0.5
Keywords in Englishmolecular subtypes, estrogen receptor, progesterone receptor, HER2 receptor, endometrial cancer
DOIDOI:10.1111/cts.12207
Languageen angielski
Score (nominal)25
ScoreMinisterial score = 25.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 25.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2014 = 1.43 (2) - 2014=1.755 (5)
Citation count*0
Cite
Share Share

Get link to the record
msginfo.png


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back